Printer Friendly

SwRI Receives $4.4 Million Contract to Develop a Drug Formulation and Delivery System to Treat Cyanide Exposure.

SAN ANTONIO -- Southwest Research Institute was awarded a $4.4 million contract from the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority to develop a nasal-delivery, first-line treatment system to combat cyanide poisoning.

Current treatments approved by the Food and Drug Administration for cyanide poisoning must be administered intravenously by qualified medical personnel. The development of a nasal formulation could potentially save lives by allowing a metered dosage to be administered immediately in the field.

"The goal of this effort is to successfully develop a supply and nasal formulation of amyl nitrite," said Dr. Joe McDonough, principal investigator and director of SwRI's Microencapsulation and Nanomaterials Department. "Amyl nitrite is relatively low cost, easily administered and broadly effective.

"Amyl nitrite can be administered intra-nasally by an individual to rapidly treat large numbers of casualties quickly and effectively. The amyl nitrite, supplied in a simple nasal delivery system, could easily be used to treat numerous victims by simple nasal instillation, and is very well suited even for self administration."

The Institute will demonstrate the safety and efficacy against cyanide exposure in two animal models to clarify a development strategy for amyl nitrite with the FDA.

The contract, awarded August 30, has a 15-month base period through December 2012 with options to extend an additional 4 years and up to $21 million.

For more information about medicinal chemistry and drug development at SwRI, please visit microencapsulation.swri.org .

About SwRI:

SwRI is an independent, nonprofit, applied research and development organization based in San Antonio, Texas, with more than 3,000 employees and an annual research volume of more than $548 million. Southwest Research Institute and SwRI are registered marks in the U.S. Patent and Trademark Office. For more information about Southwest Research Institute, please visit newsroom.swri.org or www.swri.org.
COPYRIGHT 2011 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:SwRI Receives $4.4 Million Contract to Develop a Drug Formulation and Delivery System to Treat Cyanide Exposure.
Publication:Business Wire
Geographic Code:1U7TX
Date:Sep 16, 2011
Words:359
Previous Article:Organic Farming is Superior to Conventional Agriculture According to 30-Year Comparative Study.
Next Article:Shift in Focus Provides K-Tube Technologies Customers with "Direct from the Source" Assurance.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters